Real-time quantitative PCR: a reliable molecular diagnostic and follow-up tool for ‘minimal residual disease’ assessment in chronic myeloid leukemia

Molecular monitoring of BCR-ABL transcript levels by real-time quantitative PCR is increasingly being used to diagnose the disease and assess treatment response in patients with chronic myeloid leukemia (CML). This has become particularly relevant when residual levels of leukemia usually fall below...

Descripción completa

Detalles Bibliográficos
Autores principales: Azad, Niyaz A., Shah, Zafar A., Pandith, Arshad A., Rasool, Roohi, Jeelani, Samoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172424/
https://www.ncbi.nlm.nih.gov/pubmed/30054431
http://dx.doi.org/10.1042/BSR20180974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172424/
https://www.ncbi.nlm.nih.gov/pubmed/30054431
http://dx.doi.org/10.1042/BSR20180974

Ejemplares similares